
Loading, please wait...

Loading, please wait...
"Wherever the art of Medicine is loved, there is also a love of Humanity."
— Hippocrates

Understanding long-term stroke survival is vital for optimizing post-acute care and clinical resource allocation. A recent nationwide cohort study from the Swedish Stroke Register (Riksstroke) analyzed changes in survival rates between 2013 and 2020. This research reveals significant improvements in outcomes, specifically for ischemic stroke patients, over a relatively short period.
The study included data from over 42,000 patients hospitalized for stroke. For those with ischemic stroke, 3-year survival rose from 63.8% in 2013 to 69.3% in 2020. This represent a notable 5.5 percentage point increase in survival probability. However, survival rates for intracerebral hemorrhage remained completely stagnant at 50.9% for both cohorts. These results suggest that while ischemic stroke treatments have advanced significantly, management strategies for hemorrhagic stroke have not yet achieved similar breakthroughs.
Interestingly, the most pronounced survival gains occurred among patients aged 75 years or older. This specific trend suggests that better management of chronic comorbidities and broader access to acute reperfusion therapies are benefiting elderly populations. Consequently, the survival gap between the 2013 and 2020 cohorts widened progressively during follow-up. This indicates that modern interventions provide sustained benefits that extend well beyond the initial acute phase.
Healthcare providers should recognize that stroke outcomes are improving but remain highly heterogeneous. While the gains in ischemic stroke are encouraging, the lack of progress in intracerebral hemorrhage highlights a critical need for new therapeutic research. Furthermore, the increasing survival in older adults implies a future rise in the demand for long-term geriatric rehabilitation services. Clinicians must continue to focus on strict secondary prevention to maintain these positive survival trends.
Ischemic stroke survival increased by 5.5 percentage points, reaching 69.3% in 2020 compared to 63.8% in 2013.
Researchers believe the lack of improvement is due to a shortage of decisively effective acute therapeutic strategies for intracerebral hemorrhage compared to the advancements in ischemic stroke care.
The most significant improvements in long-term stroke survival were observed in patients aged 75 years and older.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Johnsson M et al. Changes in Long-Term Survival After Stroke Between 2013 and 2020: A Nationwide Cohort Study from the Swedish Stroke Register. Int J Stroke. 2026 Apr 25. doi: 10.1177/17474930261448295. PMID: 42033194.
Toyoda K et al. Long-term Functional Outcomes Improved in Ischemic Stroke But Not Hemorrhagic. NeurologyLive. 2022.
Flint Rehab. Stroke Survival Statistics: 9 Stats Every Survivor Needs to Know. 2024.
"
3-year survival after ischemic stroke improved from 63.8% to 69.3% between 2013 and 2020, with significant gains in elderly patients....
last month

A landmark study published in Cell Genomics reveals that overcrowding, poor sanitation, and socioeconomic inequality are primary drivers of global antimicrobial resistance. Reducing antibiotic consumption alone will not suffice, highlighting the urgent need for structural public health reforms by 2050.
Today

A new study reveals that hyperactivating the Hedgehog pathway with Smoothened Agonist (SAG) causes significant craniofacial development defects in mice. By disrupting cell proliferation and cell-cycle progression during a critical window, SAG exposure leads to cleft lip and other cranial abnormalities.
Today

A study of 221 patients reveals that IVUS guidance during intracoronary brachytherapy for in-stent restenosis significantly reduces target lesion revascularization (21% vs 37%) and major adverse cardiovascular events, ensuring better long-term procedural success and improved patient safety.
Today

Despite their expertise in ergonomics, physiotherapists face high rates of work-related musculoskeletal disorders. New research identifies low back pain and repetitive tasks as leading issues, with female practitioners showing significantly higher risk profiles compared to their male counterparts.
Today

A comprehensive pathological study reveals that medial and intimal calcification follow distinct, inverse distribution patterns in the lower extremities, with medial calcification significantly linked to chronic kidney disease.
Today